$ELTP Recent Headlines Former CEO of Elite Pharm

$ELTP Recent Headlines

Former CEO of Elite Pharmaceuticals sells all shares 9:47 a.m. Oct. 28, 2004 - James Comtois
Semel's Yahoo stock sales lead weekly insider trades 3:17 p.m. Oct. 25, 2004 - James Comtois
Elite Pharma says ends Nostrum Pharma merger talks 4:19 p.m. Aug. 6, 2004 - Carla Mozee
Elite Pharmaceuticals settles w/former CEO 11:07 a.m. May 3, 2004 - Maggie McNeil
Elite settles w/former CEO, includes $400,000 payment 12:15 p.m. April 1, 2004 - Maggie McNeil
Elite Pharma to negotiate purchase of Nostrum 1:27 p.m. Aug. 8, 2003 - Chris Kraeuter

Elite Pharmaceuticals: Swinging For The Fences 10:53 a.m. Dec. 18, 2013 - Seeking Alpha
10-K: ELITE PHARMACEUTICALS INC /NV/ 12:10 p.m. June 21, 2013 - Edgar Online - (EDG = 10Q, 10K)
1 Stock to Buy, 1 Stock to Short: Pharmaceuticals 11:01 p.m. May 9, 2013 - InvestorPlace.com
10-Q: ELITE PHARMACEUTICALS INC /NV/ 4:21 p.m. Feb. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)

Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for Second Opioid Abuse Deterrent Product 1:22 p.m. Jan. 14, 2014 - GlobeNewswire
Elite Pharmaceuticals Initiates Pilot Bioequivalence Study for ELI-201 12:50 p.m. Dec. 5, 2013 - GlobeNewswire
Elite Pharmaceuticals Announces Conversion of Treppel Bridge Loan to Convertible Note 7:00 a.m. Nov. 26, 2013 - GlobeNewswire
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2014 4:23 p.m. Nov. 14, 2013 - GlobeNewswire
Elite Pharmaceuticals, Inc. to Host Second Quarter Business Update Call on November 18, 2013 7:45 a.m. Nov. 14, 2013 - GlobeNewswire
Elite Pharmaceuticals Announces Bridge Loan Facility 6:45 a.m. Oct. 16, 2013 - GlobeNewswire
Elite Pharmaceuticals Announces Manufacturing and License Agreement for Twelve Generic Products 6:45 a.m. Oct. 8, 2013 - GlobeNewswire
BlackBerry May be Going Private on Potential Fairfax Deal 8:27 a.m. Sept. 24, 2013 - ACCESSWIRE
Shutterstock Zooms to a new 52-week High after Pricing Secondary Offering 6:29 a.m. Sept. 23, 2013 - ACCESSWIRE
Elite Pharmaceuticals, Inc. Announces First Shipment of Generic Naltrexone Hydrochloride 6:51 a.m. Sept. 18, 2013 - GlobeNewswire
Elite Pharmaceuticals Announces Participation at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th 8:47 a.m. Sept. 3, 2013 - GlobeNewswire
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2014 3:30 p.m. Aug. 14, 2013 - GlobeNewswire
Elite Pharmaceuticals, Inc. Announces Fiscal Year 2014 First Quarter Conference Call on Thursday, August 15, 2013 11:00 a.m. Aug. 13, 2013 - GlobeNewswire
Elite Pharmaceuticals, Inc. Hires Industry Veteran Doug Plassche as Executive Vice President of Operations 7:01 a.m. Aug. 12, 2013 - GlobeNewswire
Elite Pharmaceuticals, Inc. Appoints Nasrat Hakim as President and Chief Executive Officer 6:00 a.m. Aug. 5, 2013 - GlobeNewswire
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2013, FQ4/13 Revenues Highest in Corporate History 12:45 p.m. June 21, 2013 - GlobeNewswire
Elite Pharmaceuticals, Inc. Announces 2013 Fiscal Year End Conference Call on Monday, June 24, 2013 7:00 a.m. June 19, 2013 - GlobeNewswire
Elite Pharmaceuticals Announces Change in Executive Leadership 10:49 a.m. May 21, 2013 - GlobeNewswire
Leading Active Companies in the News: Crown Marketing (CWNM), Nuvilex (NVLX), Elite Pharmaceuticals (ELTP), Cannabis Science (CBIS), Merck (MRK) 8:11 a.m. May 9, 2013 - ACCESSWIRE-TNW
Elite Pharmaceuticals Awarded Second U.S. Patent for Abuse Resistant Drug Formulation 7:23 a.m. April 23, 2013 - GlobeNewswire